Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38501 - 38525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	SKAP2	8935	upregulated	entinostat results in increased expression of SKAP2 mRNA	7p15.2	A21037 A21035
Entinostat	Investigational	SLC10A4	201780	upregulated	entinostat results in increased expression of SLC10A4 mRNA	4p11	A21037
Entinostat	Investigational	SLC12A8	84561	upregulated	entinostat results in increased expression of SLC12A8 mRNA	3q21.2	A21035
Entinostat	Investigational	SLC13A4	26266	upregulated	entinostat results in increased expression of SLC13A4 mRNA	7q33	A21035
Entinostat	Investigational	SLC16A1	6566	upregulated	entinostat results in increased expression of SLC16A1 mRNA	1p13.2	A21037
Entinostat	Investigational	SLC16A10	117247	upregulated	entinostat results in increased expression of SLC16A10 mRNA	6q21	A21035
Entinostat	Investigational	SLC16A14	151473	downregulated	entinostat results in decreased expression of SLC16A14 mRNA	2q36.3	A21037
Entinostat	Investigational	SLC16A1-AS1	100506392	upregulated	entinostat results in increased expression of SLC16A1-AS1 mRNA	1p13.2	A21037
Entinostat	Investigational	SLC16A3	9123	upregulated	entinostat results in increased expression of SLC16A3 mRNA	17q25.3	A21035
Entinostat	Investigational	SLC17A5	26503	upregulated	entinostat results in increased expression of SLC17A5 mRNA	6q13	A21035
Entinostat	Investigational	SLC17A6	57084	downregulated	entinostat results in decreased expression of SLC17A6 mRNA	11p14.3	A21035
Entinostat	Investigational	SLC18A2	6571	upregulated	entinostat results in increased expression of SLC18A2 mRNA	10q25.3	A21037 A21035
Entinostat	Investigational	SLC18B1	116843	upregulated	entinostat results in increased expression of SLC18B1 mRNA	6q23.2	A21037 A21035
Entinostat	Investigational	SLC19A3	80704	upregulated	entinostat results in increased expression of SLC19A3 mRNA	2q36.3	A21035
Entinostat	Investigational	SLC1A1	6505	upregulated	entinostat results in increased expression of SLC1A1 mRNA	9p24.2	A21035
Entinostat	Investigational	SLC22A16	85413	upregulated	entinostat results in increased expression of SLC22A16 mRNA	6q21	A21035
Entinostat	Investigational	SLC22A17	51310	upregulated	entinostat results in increased expression of SLC22A17 mRNA	14q11.2	A21035
Entinostat	Investigational	SLC24A3	57419	upregulated	entinostat results in increased expression of SLC24A3 mRNA	20p11.23	A21037
Entinostat	Investigational	SLC25A12	8604	upregulated	entinostat results in increased expression of SLC25A12 mRNA	2q31.1	A21037
Entinostat	Investigational	SLC25A21	89874	downregulated	entinostat results in decreased expression of SLC25A21 mRNA	14q13.3	A21035
Entinostat	Investigational	SLC25A30	253512	upregulated	entinostat results in increased expression of SLC25A30 mRNA	13q14.13	A21035
Entinostat	Investigational	SLC25A37	51312	downregulated	entinostat results in decreased expression of SLC25A37 mRNA	8p21.2	A21037
Entinostat	Investigational	SLC27A6	28965	upregulated	entinostat results in increased expression of SLC27A6 mRNA	5q23.3	A21035
Entinostat	Investigational	SLC2A12	154091	downregulated	entinostat results in decreased expression of SLC2A12 mRNA	6q23.2	A21037
Entinostat	Investigational	SLC2A12	154091	upregulated	entinostat results in increased expression of SLC2A12 mRNA	6q23.2	A21035

Displaying entries 38501 - 38525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability